ARTICLE | Company News
Matrix Pharma cancer news
October 15, 2001 7:00 AM UTC
MATX will sell its Matrix Contract Services manufacturing and packaging division and reduce headcount by 40%. The company said it will focus on development of its tezacitabine chemotherapeutic and Int...